New City Osaki Clinic homepage  >  Consultation guide  >  Seminars

Invitation to the seminar “Evolving immune cell therapy”

[2012 Seminar]
About “Immune cell therapy for cancer”
that is attracting attention as a leading-edge
cancer therapy and evolving day-by-day.

Outline of the seminar

11:00 - 12:00 (reception starts at 10:30) on January 28 (Saturday), 2012

The number of attendees is limited to 10
(the application is closed because the number of applicants reached 10).

Fee: free

Location: 2nd floor, Osaki New City TOC Building
1-6-1 Osaki, Shinagawa-ku, Tokyo, Japan 141-0032
(2-minute walk from the JR Osaki Station)
*Please see Directions for the map.

Application: Please e-mail us.

booklet “Why it is good to boost the immunity”
We will give all the attendees a booklet explaining immunity in an easy-to-understand manner,
“Why it is good to boost the immunity”

Content of the seminar

- Let’s learn about the immune system—it’s protecting our bodies
- The close relationship between the development of cancer and immunity
- Immune cells are resistant to cancer, but vulnerable to stress
- Lifestyle that strengthens immunity—promising immune activation method
- Various immune cell therapies

About the lecturers

Sanehiko Fujita Sanehiko Fujita
(Director, New City Osaki Clinic)

Dr. Fujita focuses on community healthcare and is committed to contributing to the eradication of cancer through medical consultation, treatment, and preventive medicine. As a family doctor, he aims to have open communication with patients, and to provide compassionate medical care.

Junichi Masuyama Junichi Masuyama
(New City Osaki Clinic)

Dr. Masuyama has long been conducting basic and clinical studies of immune cells and succeeded in high level of activation and culture of a large amount of NK cells. He engages in research, treatment, and education, with a sense of mission to save as many people with cancer as possible.

*Please see Introduction to our physicians for the details.

Return to the top


Cancer immunotherapy

Immune system | Cancer immunotherapy | Highly active NK cell therapy | Problems of highly active NK cells | Characteristics of highly active NK cells | “immunity-enhancing effect” of highly active NK cells | Recommendation of highly active NK cell therapy